| Literature DB >> 34225807 |
Mei-Ping Wang1,2, Li Jiang3, Bo Zhu2, Bin Du4, Wen Li2, Yan He5, Xiu-Ming Xi6.
Abstract
BACKGROUND: Septic shock has a high incidence and mortality rate in Intensive Care Units (ICUs). Earlier intravenous fluid resuscitation can significantly improve outcomes in septic patients but easily leads to fluid overload (FO), which is associated with poor clinical outcomes. A single point value of fluid cannot provide enough fluid information. The aim of this study was to investigate the impact of fluid balance (FB) latent trajectories on clinical outcomes in septic patients.Entities:
Keywords: Clinical outcomes; Fluid overload; Group-based trajectory model; Septic shock
Year: 2021 PMID: 34225807 PMCID: PMC8258941 DOI: 10.1186/s40779-021-00328-1
Source DB: PubMed Journal: Mil Med Res ISSN: 2054-9369
Fig. 1Flowchart of the patients included in the study. CCCST China Critical Care Sepsis Trial
Baseline characteristics of the study patients according to the 3 subgroups with different fluid balance trajectory patterns
| Characteristics | All ( | Fluid balance trajectory patterns | |||
|---|---|---|---|---|---|
| Decreasing FB | Low FB | High FB | |||
| Fluid overload | 198 (20.1) | 33 (51.6) | 87 (10.3) § | 78 (96.3)§ | < 0.001 |
| Age (year, | 63.7 ± 17.5 | 66.3 ± 18.9 | 63.3 ± 17.3 | 65.3 ± 18.6 | 0.292 |
| Sex [male, | 624 (63.3) | 37 (57.8) | 535 (63.6) | 52 (64.2) | 0.640 |
| APACHE II ( | 22.1 ± 7.8 | 24.7 ± 7.4 | 21.6 ± 7.8§ | 25.4 ± 7.4 | < 0.001 |
| SOFA [M (IQR)] | 8.0 (6.0–11.0) | 11.0 (8.0–13.0) | 8.0 (5.0–10.0)§ | 10.5 (8.0–13.0)§ | < 0.001 |
| Source of admission [ | 0.006 | ||||
| Emergency department | 175 (17.7) | 12 (18.8) | 143 (17.0) | 20 (24.7) | |
| Medical | 659 (66.8) | 33 (51.6) | 575 (68.4)§ | 51 (63.0)§ | |
| Surgical | 152 (15.4) | 19 (29.7) | 123 (14.6)§ | 10 (12.3)§ | |
| Comorbidities [ | |||||
| Respiratory disease | 76 (7.7) | 5 (7.8) | 64 (7.6) | 7 (8.6) | 0.946 |
| Cardiovascular disease | 155 (15.7) | 11 (17.2) | 130 (15.5) | 14 (17.3) | 0.862 |
| Hypertension | 326 (33.1) | 19 (29.7) | 284 (33.4) | 23 (28.4) | 0.518 |
| Diabetes mellitus | 192 (19.5) | 9 (14.1) | 167 (19.9) | 16 (19.8) | 0.528 |
| Cancer | 117 (11.9) | 11 (17.2) | 92 (10.9) | 14 (17.3) | 0.096 |
| None | 189 (19.2) | 24 (37.5) | 146 (17.7)§ | 19 (23.5)§ | < 0.001 |
| Treatments [ | |||||
| MV | 826 (83.8) | 62 (96.9) | 691 (82.2)§ | 73 (90.1)§ | 0.002 |
| Renal replacement therapy | 229 (23.2) | 12 (18.8) | 178 (21.2) | 39 (48.1)§ | < 0.001 |
FB fluid balance, SD standard deviation, IQR interquartile range, APACHE II acute physiology and chronic health evaluation II, SOFA sequential organ failure assessment, MV mechanical ventilation, §Compared with decreasing FB, P < 0.05
Fig. 2Fluid balance trajectory patterns during the first 7 days after admission to the ICU. FB fluid balance
Fig. 3Daily and cumulative fluid balances in the three subgroups with different trajectory patterns. *Compared with decreasing FB, P < 0.05; FB fluid balance
Clinical outcomes of the study patients with different fluid balance trajectory patterns
| Characteristics | All ( | Fluid balance trajectory patterns | |||
|---|---|---|---|---|---|
| Decreasing FB | Low FB | High FB | |||
| Clinical outcomes [ | |||||
| Hospital mortality | 430 (43.6) | 30 (46.9) | 342 (40.7) | 58 (71.6)§ | < 0.001 |
| Organ dysfunction | 613 (62.2) | 30 (46.9) | 519 (61.7) | 64 (79.0)§ | < 0.001 |
| MAKE | 499 (50.6) | 33 (51.6) | 399 (47.4)§ | 67 (82.7)§ | < 0.001 |
| SRAE | 373 (37.8) | 19 (29.7) | 307 (36.5) | 47 (58.0)§ | 0.014 |
| Length of stay [d, M (IQR)] | |||||
| Hospital* | 20.0 (12.0–30.0) | 21.0 (13.0–31.0) | 19.0 (12.0–30.0) | 20.0 (8.0–35.0) | 0.576 |
| ICU* | 10.0 (5.0–16.0) | 12.0 (8.0–17.0) | 10.0 (5.0–16.0) | 9.0 (4.0–23.0) | 0.128 |
FB fluid balance, IQR interquartile range, MAKE major adverse kidney events, SRAE severe respiratory adverse events, *For survivors; §Compared with decreasing FB, P < 0.05
Hazard ratio or odds ratio for risks of clinical outcomes by the 3 subgroups of different fluid balance trajectory patterns
| Clinical outcome | Events [ | Adjusted | |
|---|---|---|---|
| Primary outcome | |||
| Hospital mortality | |||
| Low FB | 342 (40.7) | 1.00 | |
| High FB | 58 (71.6) | 1.63 (1.22–2.17) | 0.001 |
| Decreasing FB | 30 (46.9) | 0.86 (0.59–1.26) | 0.331 |
| Secondary outcome | |||
| Organ dysfunction | |||
| Low FB | 519 (61.7) | 1.00 | |
| High FB | 64 (79.0) | 2.18 (1.22–3.42) | 0.006 |
| Decreasing FB | 30 (46.9) | 0.70 (0.40–1.02) | 0.051 |
| MAKE | |||
| Low FB | 399 (66.1) | 1.00 | |
| High FB | 67 (82.7) | 1.80 (1.04–2.63) | 0.035 |
| Decreasing FB | 33 (51.6) | 0.46 (0.29–0.79) | 0.004 |
| SRAE | |||
| Low FB | 307 (36.5) | 1.00 | |
| High FB | 47 (58.0) | 2.33 (1.46–3.71) | 0.001 |
| Decreasing FB | 19 (29.7) | 0.73 (0.42–1.28) | 0.143 |
FB fluid balance, MAKE major adverse kidney events, SRAE severe respiratory adverse events, CI confidence interval, OR odds ratio, HR hazard ratio